These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2333 related articles for article (PubMed ID: 11594942)

  • 1. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
    Age-Related Eye Disease Study Research Group
    Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.
    Age-Related Eye Disease Study Research Group
    Arch Ophthalmol; 2001 Oct; 119(10):1439-52. PubMed ID: 11594943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Kurinij N; Davis MD;
    Ophthalmology; 2013 Aug; 120(8):1604-11.e4. PubMed ID: 23582353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000253. PubMed ID: 28756617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
    JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.
    Clemons TE; Kurinij N; Sperduto RD;
    Arch Ophthalmol; 2004 May; 122(5):716-26. PubMed ID: 15136320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
    Awh CC; Lane AM; Hawken S; Zanke B; Kim IK
    Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current use of dietary supplementation in patients with age-related macular degeneration.
    Chang CW; Chu G; Hinz BJ; Greve MD
    Can J Ophthalmol; 2003 Feb; 38(1):27-32. PubMed ID: 12608514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
    ; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
    Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.
    Clemons TE; Milton RC; Klein R; Seddon JM; Ferris FL;
    Ophthalmology; 2005 Apr; 112(4):533-9. PubMed ID: 15808240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS; Wang JJ; Flood V; Rochtchina E; Smith W; Mitchell P
    Ophthalmology; 2008 Feb; 115(2):334-41. PubMed ID: 17664009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.
    Bressler NM; Bressler SB; Congdon NG; Ferris FL; Friedman DS; Klein R; Lindblad AS; Milton RC; Seddon JM;
    Arch Ophthalmol; 2003 Nov; 121(11):1621-4. PubMed ID: 14609922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
    JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 41.
    Vitale S; Agrón E; Clemons TE; Keenan TDL; Domalpally A; Danis RP; Chew EY
    JAMA Ophthalmol; 2020 Jun; 138(6):610-617. PubMed ID: 32271358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000254. PubMed ID: 23152201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 117.